All News

    Breaking Down the Safety of BCG in Patients With NMIBC

    January 31st 2025, 8:00pm

    Article

    BCG therapy is associated with a high frequency of side effects in NMIBC; however, when used in sequential combination with chemo, fewer were reported.

    Why Hope is Important For Patients with Chronic Lymphocytic Leukemia

    January 31st 2025, 6:00pm

    Article

    Hope is crucial for those of us with chronic lymphocytic leukemia, or any cancer, helping us navigate the disease's challenges.

    Dwyane Wade Talks Tumor Removal, Bachelorette Star’s Husband Cancer Diagnosis and More

    January 31st 2025, 4:00pm

    Article

    From the reveal of NBA star Dwyane Wade’s cancer surgery to a Bachelorette star on her husband’s cancer diagnosis, here is this week’s top cancer news.

    Keytruda and Lenvima Combo Misses OS Mark in HER2– Gastroesophageal Cancer

    January 31st 2025, 2:00pm

    Article

    In the LEAP-015 trial, Keytruda and Lenvima plus chemo did not meet the primary end point of overall survival in HER2– gastroesophageal adenocarcinoma.

    Galinpepimut-S Immunotherapy Has Preliminary Efficacy in Acute Myeloid Leukemia

    January 30th 2025, 10:00pm

    Article

    Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission following second-line salvage therapy.

    Herceptin Combo Shows Limited Benefit in Gastric/GEJ Cancer

    January 30th 2025, 7:43pm

    Article

    In the INNOVATION trial, adding Herceptin and Perjeta to chemotherapy increased toxicity in patients with HER2-positive gastric cancers.

    Strutting Into Year 11 With Metastatic Breast Cancer

    January 30th 2025, 6:00pm

    Article

    After living with metastatic breast cancer for 11 years, I reflect on my journey and plan to embrace the coming year with confidence and self-advocacy.

    How Do Molecular Factors Impact Response to Immunotherapy in Kidney Cancer?

    January 30th 2025, 4:00pm

    Video

    Dr. David A. Braun delved into the molecular factors which drive exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.

    Itovebi-Based Treatment Has OS Benefit in PIK3CA+ HR+/HER2– Breast Cancer

    January 30th 2025, 2:00pm

    Article

    Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated positive overall survival results.

    A Phase 1 Trial of Iadademstat Plus Vidaza Has Dosed a Patient With MDS

    January 29th 2025, 10:00pm

    Article

    The first patient has been dosed in a phase 1 dose-finding clinical trial evaluating iadademstat with Vidaza in patients with myelodysplastic syndrome.